U.S. flag

An official website of the United States government

NM_000257.4(MYH7):c.4807G>A (p.Ala1603Thr) AND Cardiovascular phenotype

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 24, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000620277.3

Allele description [Variation Report for NM_000257.4(MYH7):c.4807G>A (p.Ala1603Thr)]

NM_000257.4(MYH7):c.4807G>A (p.Ala1603Thr)

Genes:
LOC126861897:BRD4-independent group 4 enhancer GRCh37_chr14:23884455-23885654 [Gene]
MYH7:myosin heavy chain 7 [Gene - OMIM - HGNC]
MHRT:myosin heavy chain associated RNA transcript [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
14q11.2
Genomic location:
Preferred name:
NM_000257.4(MYH7):c.4807G>A (p.Ala1603Thr)
Other names:
p.A1603T:GCA>ACA
HGVS:
  • NC_000014.9:g.23416150C>T
  • NG_007884.1:g.24512G>A
  • NM_000257.4:c.4807G>AMANE SELECT
  • NP_000248.2:p.Ala1603Thr
  • LRG_384t1:c.4807G>A
  • LRG_384:g.24512G>A
  • NC_000014.8:g.23885359C>T
  • NM_000257.2:c.4807G>A
  • NM_000257.3:c.4807G>A
  • NR_126491.1:n.411C>T
Protein change:
A1603T
Links:
dbSNP: rs730880809
NCBI 1000 Genomes Browser:
rs730880809
Molecular consequence:
  • NM_000257.4:c.4807G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_126491.1:n.411C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000735988Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Aug 24, 2017)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Development of a high resolution melting method for the detection of genetic variations in hypertrophic cardiomyopathy.

Millat G, Chanavat V, Créhalet H, Rousson R.

Clin Chim Acta. 2010 Dec 14;411(23-24):1983-91. doi: 10.1016/j.cca.2010.08.017. Epub 2010 Aug 26.

PubMed [citation]
PMID:
20800588

Details of each submission

From Ambry Genetics, SCV000735988.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The p.A1603T variant (also known as c.4807G>A), located in coding exon 32 of the MYH7 gene, results from a G to A substitution at nucleotide position 4807. The alanine at codon 1603 is replaced by threonine, an amino acid with similar properties. This alteration was reported in a cohort of individuals with hypertrophic cardiomyopathy; however, limited clinical information was provided (Millat G et al. Clin. Chim. Acta, 2010 Dec;411:1983-91). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024